Panel Discussion | Thrombus Management and Anticoagulation

Sunday, March 9, 2025

4:06 PM – 4:25 PM ET

Panel Moderator(s)

Usman Baber, MD, MS

Professor of Medicine
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States

Disclosure(s): Abbott Cardiovascular Systems: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
David Cox, MD, MSCAI

Interventional Cardiologist
Sanger HVI Charlotte NC
Charlotte, North Carolina, United States

Disclosure(s): No financial relationships to disclose
Luis Ortega-Paz, MD, PhD

Assistant professor
University of Florida College of Medicine-Jacksonville
Jacksonville, Florida, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Marc Cohen, MD

Chair of Medicine
Newark Beth Israel Med Ctr
Philadelphia, Pennsylvania, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Daiichi Sankyo, Boeringer Ingelheim , Sanofi, AstraZeneca , Chiesi, Bracco, Amgen, Novo Nordisk, Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
George Dangas, MD, MACC, MSCAI

PROFESSOR OF CARDIOLOGY
The Mount Sinai Hospital
New York, New York, United States

Disclosure(s): No financial relationships to disclose
C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s): Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing)
Paul A. Gurbel, MD, FSCAI

Director
Sinai Center for Thrombosis Research and Drug Development
Baltimore, Maryland, United States

Disclosure(s): No financial relationships to disclose
Adnan Kastrati, MD

Senior Consultant, Head of Catheterization Laboratory
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Usman Baber, MD, MS: Abbott Cardiovascular Systems: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

David Cox, MD, MSCAI: No financial relationships to disclose

Luis Ortega-Paz, MD, PhD: No financial relationships to disclose

Surendra Avula, MD, FACC: No financial relationships to disclose

Marc Cohen, MD: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Daiichi Sankyo, Boeringer Ingelheim , Sanofi, AstraZeneca , Chiesi, Bracco, Amgen, Novo Nordisk, Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

George Dangas, MD, MACC, MSCAI: No financial relationships to disclose

C. Michael Gibson, MD: Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing)

Paul A. Gurbel, MD, FSCAI: No financial relationships to disclose

Adnan Kastrati, MD: No financial relationships to disclose

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)